Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb;56(1):1-9.
doi: 10.1016/j.jmii.2022.10.003. Epub 2022 Oct 15.

Long COVID: An inevitable sequela of SARS-CoV-2 infection

Chih-Cheng Lai  1 , Chi-Kuei Hsu  2 , Muh-Yong Yen  3 , Ping-Ing Lee  4 , Wen-Chien Ko  5 , Po-Ren Hsueh  6
Affiliations
Review

Long COVID: An inevitable sequela of SARS-CoV-2 infection

Chih-Cheng Lai et al. J Microbiol Immunol Infect. 2023 Feb.

Abstract

At present, there are more than 560 million confirmed cases of the coronavirus disease 2019 (COVID-19) worldwide. Although more than 98% of patients with severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection can survive acute COVID, a significant portion of survivors can develop residual health problems, which is termed as long COVID. Although severe COVID-19 is generally associated with a high risk of long COVID, patients with asymptomatic or mild disease can also show long COVID. The definition of long COVID is inconsistent and its clinical manifestations are protean. In addition to general symptoms, such as fatigue, long COVID can affect many organ systems, including the respiratory, neurological, psychosocial, cardiovascular, gastrointestinal, and metabolic systems. Moreover, patients with long COVID may experience exercise intolerance and impaired daily function and quality of life. Long COVID may be caused by SARS-CoV-2 direct injury or its associated immune/inflammatory response. Assessment of patients with long COVID requires comprehensive evaluation, including history taking, physical examination, laboratory tests, radiography, and functional tests. However, there is no known effective treatment for long COVID. Based on the limited evidence, vaccines may help to prevent the development of long COVID. As long COVID is a new clinical entity that is constantly evolving, there are still many unknowns, and further investigation is warranted to enhance our understanding of this disease.

Keywords: COVID-19; Long COVID; Post-acute COVID; SARS-CoV-2; Vaccine.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Clinical manifestations of long coronavirus disease (COVID).,,
See this image and copyright information in PMC

References

    1. World Health Organization https://covid19.who.int/
    1. Lai C.C., Liu Y.H., Wang C.Y., Wang Y.H., Hsueh S.C., Yen M.Y., et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths. J Microbiol Immunol Infect. 2020;53:404–412. - PMC - PubMed
    1. Shao W., Zhang W., Fang X., Yu D., Wang X. Challenges of SARS-CoV-2 omicron variant and appropriate countermeasures. J Microbiol Immunol Infect. 2022;55:387–394. - PMC - PubMed
    1. Cheng M.Y., Hsih W.H., Ho M.W., Lai Y.C., Liao W.C., Chen C.Y., et al. Younger adults with mild-to-moderate COVID-19 exhibited more prevalent olfactory dysfunction in Taiwan. J Microbiol Immunol Infect. 2021;54:794–800. - PMC - PubMed
    1. Lin K.Y., Wu P.Y., Liu W.D., Sun H.Y., Hsieh S.M., Sheng W.H., et al. Effectiveness of COVID-19 vaccination among people living with HIV during a COVID-19 outbreak. J Microbiol Immunol Infect. 2022;55:535–539. - PMC - PubMed